rs753558336
Variant summary
Our verdict is Likely pathogenic. Variant got 6 ACMG points: 6P and 0B. PM2PM5PP3_Moderate
The NM_001080467.3(MYO5B):c.946G>A(p.Gly316Arg) variant causes a missense, splice region change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000187 in 1,605,034 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 13/23 in silico tools predict a damaging outcome for this variant. 2/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G316V) has been classified as Pathogenic.
Frequency
Consequence
NM_001080467.3 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MYO5B | NM_001080467.3 | c.946G>A | p.Gly316Arg | missense_variant, splice_region_variant | 8/40 | ENST00000285039.12 | NP_001073936.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MYO5B | ENST00000285039.12 | c.946G>A | p.Gly316Arg | missense_variant, splice_region_variant | 8/40 | 1 | NM_001080467.3 | ENSP00000285039.6 | ||
MYO5B | ENST00000697219.1 | c.742G>A | p.Gly248Arg | missense_variant, splice_region_variant | 6/38 | ENSP00000513188.1 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152168Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000681 AC: 17AN: 249472Hom.: 0 AF XY: 0.0000517 AC XY: 7AN XY: 135352
GnomAD4 exome AF: 0.0000179 AC: 26AN: 1452866Hom.: 0 Cov.: 30 AF XY: 0.0000180 AC XY: 13AN XY: 723460
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152168Hom.: 0 Cov.: 32 AF XY: 0.0000404 AC XY: 3AN XY: 74332
ClinVar
Submissions by phenotype
Congenital microvillous atrophy Pathogenic:1Uncertain:1
Pathogenic, criteria provided, single submitter | research | Center for Genomic Medicine, King Faisal Specialist Hospital and Research Center | Mar 17, 2024 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Apr 27, 2017 | The MYO5B c.946G>A (p.Gly316Arg) variant has been reported in a single study in which it was found in a homozygous state in one individual diagnosed with diarrhea with microvillus atrophy (Szperl et al. 2011). The variant was absent from 50 ethnically matched control individuals and is reported at a frequency of 0.00095 in the Latino population of the Exome Aggregation Consortium. The variant results in a substitution of a small aliphatic residue with a large charged arginine and affects residues localized in critical regions of the motor domain which is important for allosteric rearrangements (van der Velde et al. 2013). The evidence for this variant is limited. The p.Gly316Arg variant is therefore classified as a variant of unknown significance but suspicious for pathogenicity for diarrhea with microvillus atrophy. This variant was observed by ICSL as part of a predisposition screen in an ostensibly healthy population. - |
not provided Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | Revvity Omics, Revvity | Aug 30, 2021 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Dec 07, 2023 | In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 25525159, 21206382, 24014347, 33864888) - |
MYO5B-related disorder Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | Nov 18, 2022 | The MYO5B c.946G>A variant is predicted to result in the amino acid substitution p.Gly316Arg. This variant was reported in the homozygous state in an individual with microvillus inclusion disease and in an individual with IPEX (Immune dysregulation, polyendocrinopathy, enteropathy, X-linked)-like syndrome (Szperl et al 2011. PubMed ID: 21206382; Baxter SK et al 2021. PubMed ID: 33864888). This variant is reported in 0.037% of alleles in individuals of Latino descent in gnomAD (http://gnomad.broadinstitute.org/variant/18-47511088-C-T). Although we suspect that this variant may be pathogenic, at this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at